TNFAIP8 and skin neoplasm: Further, we demonstrated that miR-205-5p controls TNFAIP8 expression and reduces skin cancer cell survival, and increases sensitivity to the B-RAFV600E mutant kinase inhibitor vemurafenib in melanoma cells.